Treating post-dural puncture headache with theophylline, sumatriptan, or gabapentin
Official title: A Comparison Between Safety and Efficacy of Theophylline, Versus Sumatriptan and Gabapentin in The Treatment of Post-Dural Puncture Headache: A Prospective Randomized Double Blinded Study
Run by Tanta University · NCT07515456 · Data updated 2026-11-12
This trial will try theophylline, sumatriptan, and gabapentin to see which best relieves moderate-to-severe post-dural puncture headache in adults aged 21–50.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 21 Years to 50 Years |
| Sex | All |
| Enrollment | 75 (estimated) |
| Sponsor | Tanta University Academic / other |
| Locations | 1 site (Tanta, El-Gharbia) |
| Status | Recruiting |
| Started | December 1, 2024 |
| Main results expected | November 1, 2026 |
| Study ends | November 1, 2026 |
| Registry record updated | April 7, 2026 |
| Trial ID | NCT07515456 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults 21–50 years old with PDPH meeting International Headache Society criteria, ASA physical status I–II, and a numeric pain rating of ≥5 are the intended participants.
✕Probably not a fit
People who are pregnant, have chronic headache disorders, significant cardiovascular disease, thyroid/liver/kidney impairment, or contraindications to the study drugs are unlikely to benefit from these treatments.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Adults aged 21–50 with clinically diagnosed post-dural puncture headache and a pain score of at least 5 are enrolled at Tanta University and given one of three medications (theophylline, sumatriptan, or gabapentin). The study compares how well each drug reduces headache severity and records side effects to compare safety. Treatments are given per protocol and patients are followed for clinical response and adverse events. Outcomes focus on pain relief magnitude and tolerability.
Why it matters
Potential benefit: If successful, the trial could identify an effective, low-cost medication option to relieve PDPH without needing invasive procedures.
How similar studies have gone: Smaller previous reports have suggested benefit from theophylline and sumatriptan for PDPH, but direct head-to-head comparative data are limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age from 21 to 50 years. * Both sexes. * American Society of Anesthesiologists (ASA) physical status ≤ II. * Patient's selection for this study will be based on clinical diagnosis suggesting post-dural puncture headache (PDPH) based on the International Headache Society criteria. * Patients with numeric rating scale (NRS) of ≥ 5. Exclusion Criteria: * Pregnant women. * History of; chronic headache, cluster headache, migraine, convulsions, cerebrovascular accident, and previous neurological diseases. * Signs of meningismus. * Dysrhythmia. * Hypertension. * Ischemic heart disease. * Hyperthyroidism. * Peripheral vascular disease (ischemic colitis). * Liver or renal impairment. * Use of selective serotonin reuptake inhibitors. * Use of ergotamine derivatives in the past 24 hours. * Use of monoamine oxidase inhibitors in the last 2 weeks. * Use of any kind of opiates. * Allergy to the study medications and any contraindication of oral intake.
Where it's running
-
Tanta University
Tanta, El-Gharbia, Egypt Recruiting
Study contacts
- Study coordinator: Asmaa R Eid, MSc
- Email: asmaaragabeid@gmail.com
- Phone: 00201026382543
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Epidural hydroxyethyl starch to prevent post-dural puncture headache in parturients
This study tests whether filling the epidural space with hydroxyethyl starch can help prevent post-dural puncture headaches in women who had an accidental dural puncture during epidural anesthesia for labor or cesarean delivery.
-
Predicting Post-Dural Puncture Headache After Spinal Anesthesia in Cesarean Deliveries
This study tests whether changes in optic nerve sheath diameter after spinal anesthesia can predict who will develop a post-dural puncture headache in pregnant women having an elective cesarean.
-
Sphenopalatine ganglion block versus epidural blood patch for post-dural puncture headache
This test compares a sphenopalatine ganglion block and an epidural blood patch to see which relieves post-dural puncture headaches better in adults whose pain hasn't improved after 24 hours of usual treatment.
-
Nebulized neostigmine/atropine versus nebulized lidocaine for post-dural puncture headache after cesarean delivery
This trial tests whether inhaled (nebulized) neostigmine with atropine relieves post-dural puncture headache better than inhaled lidocaine in women who develop headache after spinal anesthesia for elective cesarean delivery.
-
Exploring causes and treatments for postural puncture headache
This study is trying to understand what causes post-dural puncture headaches and how treatments like epidural blood patches can help people who get them after a lumbar puncture.
-
Impact of altitude on headaches after cesarean delivery
This study is testing how living at different altitudes affects the headaches that women experience after having a cesarean delivery with spinal anesthesia.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.